会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • POLYPEPTIDES WITH LIPASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME
    • 具有脂酶活性的多肽和编码其的多核苷酸
    • WO2014147127A1
    • 2014-09-25
    • PCT/EP2014/055509
    • 2014-03-19
    • NOVOZYMES A/S
    • MORANT, Marc DominiqueREISER, Anna VerenaHANSEN, Carsten HoerslevBORCH, KimBAUNSGAARD, LoneBHATIA, Vikram Kjoeller
    • C11D3/386C12N9/20
    • C11D3/38627C11D3/38681C12N9/20C12P13/008
    • The present invention relates to isolated polypeptides with lipase activity, selected from the group consisting of:(a)a polypeptide having at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to SEQ ID NO: 4;(b)a polypeptide encoded by a polynucleotide that hybridizes under low stringency conditions, medium stringency conditions, medium-high stringency conditions, high stringency conditions, or very high stringency conditions with (i) SEQ ID NO: 3or the full-length complement of (i);(c)a polypeptide encoded by a polynucleotide having at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to SEQ ID NO: 3;(d)a polypeptide which is a variant of SEQ ID NO: 4 comprising a substitution, deletion, and/or insertion at one or more (e.g. several) positions; and(e)a polypeptide which is a fragment of any of the polypeptides of (a), (b), (c) or (d).The invention also relates to polynucleotides encoding the polypeptides; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the polypeptides.
    • 本发明涉及具有脂肪酶活性的分离的多肽,其选自:(a)多肽,其具有至少75%,至少80%,至少85%,至少90%,至少91%,在 与SEQ ID NO:4的至少92%,至少93%,至少94%,至少95%,至少96%,至少97%,至少98%,至少99%或100%的序列同一性 ;(b)由多核苷酸编码的多肽,其在低严格条件,中等严格条件,中等严格条件,高严格条件或非常高严格条件下与(i)SEQ ID NO:3或全长补体 (c)由多核苷酸编码的多肽,所述多核苷酸具有至少75%,至少80%,至少85%,至少90%,至少91%,至少92%,至少93% 与SEQ ID NO:3的至少94%,至少95%,至少96%,至少97%,至少98%,至少99%或100%的序列同一性;(d) SEQ ID NO:4的变体包含取代, 和/或插入在一个或多个(例如, 几个)职位; (e)多肽,其是(a),(b),(c)或(d)的多肽的片段。本发明还涉及编码多肽的多核苷酸; 核酸构建体,载体和包含多核苷酸的宿主细胞; 和使用多肽的方法。
    • 4. 发明申请
    • POLYPEPTIDES WITH LIPASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME
    • 具有脂酶活性的多肽和编码其的多核苷酸
    • WO2015004102A1
    • 2015-01-15
    • PCT/EP2014/064540
    • 2014-07-08
    • NOVOZYMES A/S
    • MORANT, Marc DominiqueREISER, Anna VerenaHANSEN, Carsten HoerslevBORCH, KimBAUNSGAARD, LoneBHATIA, Vikram Kjoeller
    • C12N9/20
    • C12N9/20C11D3/38627C11D3/38681C12Y301/01C12Y301/01003D06L4/40
    • The present invention relates to isolated polypeptides with lipase activity, selected from the group consisting of: (a)a polypeptide having at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to SEQ ID NO: 2; (b) a polypeptide encoded by a polynucleotide that hybridizes under low stringency conditions, medium stringency conditions, medium-high stringency conditions, high stringency conditions, or very high stringency conditions with (i) SEQ ID NO: 1or the full-length complement of (i); (c)a polypeptide encoded by a polynucleotide having at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to SEQ ID NO: 1; (d) a polypeptide which is a variant of SEQ ID NO: 2 comprising a substitution, deletion, and/or insertion at one or more (e.g. several) positions; and(e)a polypeptide which is a fragment of any of the polypeptides of (a), (b), (c) or (d).The invention also relates to polynucleotides encoding the polypeptides; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the polypeptides.
    • 本发明涉及具有脂肪酶活性的分离的多肽,其选自:(a)多肽,其具有至少80%,至少85%,至少90%,至少91%,至少92%,在 与SEQ ID NO:2的至少93%,至少94%,至少95%,至少96%,至少97%,至少98%,至少99%或100%的序列同一性; (b)由多核苷酸编码的多肽,其在低严格条件,中等严格条件,中等严格条件,高严格条件或非常高严格条件下与(i)SEQ ID NO:1或全长互补的 (一世); (c)由多核苷酸编码的多肽,所述多肽具有至少80%,至少85%,至少90%,至少91%,至少92%,至少93%,至少94%,至少95% 与SEQ ID NO:1的至少96%,至少97%,至少98%,至少99%或100%的序列同一性; (d)在一个或多个(例如多个)位置上包含取代,缺失和/或插入的SEQ ID NO:2的变体的多肽; (e)多肽,其是(a),(b),(c)或(d)的多肽的片段。本发明还涉及编码多肽的多核苷酸; 核酸构建体,载体和包含多核苷酸的宿主细胞; 和使用多肽的方法。
    • 5. 发明申请
    • COMPOSITIONS AND PROCESSES FOR TREATMENT WITH LIPASES
    • 用于治疗的组合物和方法
    • WO2015091746A1
    • 2015-06-25
    • PCT/EP2014/078389
    • 2014-12-18
    • NOVOZYMES A/S
    • MORANT, Marc DominiqueREISER, Anna VerenaHANSEN, Carsten HoerslevBORCH, KimBAUNSGAARD, LoneBHATIA, Vikram Kjoeller
    • C11D3/386
    • C11D3/38627
    • The present invention relates to a composition comprising: (a) at least one surfactant, at least one surfactant system, at least one soap, or any mixtures thereof; and (b) a polypeptide having lipase activity selected from the group consisting of: (I) a polypeptide having at least 80% sequence identity to the mature polypeptide of SEQ ID NO: 2; (II) a polypeptide encoded by a polynucleotide that hybridizes under low stringency conditions with (i) the mature polypeptide coding sequence of SEQ ID NO: 1, or (ii) the full-length complement of (i); (III) a polypeptide encoded by a polynucleotide having at least 80% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 1; (IV) a variant of the mature polypeptide of SEQ ID NO: 2 comprising a substitution, deletion, and/or insertion at one or more positions; and (V) a fragment of the polypeptide of (I), (II), (III), or (IV); wherein said composition is a cleaning and/or treatment composition. The invention furthermore relates to methods of producing and using the composition.
    • 本发明涉及一种组合物,其包含:(a)至少一种表面活性剂,至少一种表面活性剂体系,至少一种皂或其任何混合物; 和(b)具有选自以下的脂肪酶活性的多肽:(I)与SEQ ID NO:2的成熟多肽具有至少80%序列同一性的多肽; (II)由寡核苷酸编码的多肽,其在低严格条件下与(i)SEQ ID NO:1的成熟多肽编码序列杂交,或(ii)全长互补序列(i); (III)由与SEQ ID NO:1的成熟多肽编码序列具有至少80%序列同一性的多核苷酸编码的多肽; (IV)SEQ ID NO:2的成熟多肽的变体,其在一个或多个位置包含取代,缺失和/或插入; 和(V)(I),(II),(III)或(IV)的多肽的片段; 其中所述组合物是清洁和/或治疗组合物。 本发明还涉及生产和使用该组合物的方法。